Insight Molecular Diagnostics Inc. (IMDX) Operating Margin
- Operating margin · 12 months: Value -3011.86%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -3011.86% | Operating income / revenue. Period ending 2026-06-30. $-50.30M ÷ $1.67M × 100 ≈ -3011.86% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -50.30M USD | Operating Income (Loss) |
| Revenue | 1.67M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | 19.15M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-50.30M | $1.67M | (m) | $19.15M | (m) | -3011.86% |
| 2026-03-31 | $-48.74M | $1.95M | (m) | $17.93M | (m) | -2500.67% |
| 2025-12-31 | $-51.12M | $4.05M | (m) | $15.90M | (m) | -1260.76% |
| 2025-09-30 | $-61.32M | $4.40M | (m) | $12.33M | (m) | -1392.91% |
| 2025-06-30 | $-63.78M | $4.26M | (m) | $11.28M | (m) | -1498.31% |
| 2025-03-31 | $-58.57M | $3.84M | (m) | $10.45M | (m) | -1524.15% |
| 2024-12-31 | $-61.04M | $1.88M | (m) | $9.84M | (m) | -3245.14% |
| 2024-09-30 | $-43.59M | $709.00K | (m) | $10.13M | (m) | -6148.52% |
| 2024-06-30 | $-36.59M | $1.02M | (m) | $9.50M | (m) | -3576.83% |
| 2024-03-31 | $-40.25M | $1.38M | (m) | $9.34M | (m) | -2912.66% |
| 2023-12-31 | $-25.14M | $1.50M | (m) | $9.29M | (m) | -1672.39% |
| 2023-09-30 | $-20.61M | $1.46M | (m) | $8.13M | (m) | -1408.41% |
| 2023-06-30 | $-15.80M | $1.10M | (m) | $7.41M | (m) | -1434.88% |
| 2023-03-31 | $-9.18M | $875.00K | (m) | $7.42M | (m) | -1049.37% |
| 2022-12-31 | $-18.00M | $958.00K | (m) | $7.30M | (m) | -1878.60% |
| 2022-09-30 | $-63.36M | $8.10M | (m) | $19.71M | (m) | -782.49% |
| 2022-06-30 | $-67.74M | $8.06M | (m) | $18.43M | (m) | -840.04% |
| 2022-03-31 | $-72.75M | $8.03M | (m) | $15.40M | (m) | -906.28% |
| 2021-12-31 | $-74.21M | $7.73M | (m) | $13.63M | (m) | -960.42% |
| 2021-09-30 | $-44.80M | $4.64M | (m) | $10.84M | (m) | -965.29% |
| 2021-06-30 | $-37.44M | $4.21M | (m) | $10.31M | (m) | -888.87% |
| 2021-03-31 | $-32.64M | $2.32M | (m) | $11.00M | (m) | -1404.48% |
| 2021-02-23 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $-29.71M | $1.22M | (m) | $9.80M | (m) | -2443.34% |
| 2020-09-30 | $-30.97M | (m) | (m) | $10.32M | (m) | (m) |
| 2020-06-30 | $-29.98M | (m) | (m) | $9.33M | (m) | (m) |
| 2020-03-31 | $-26.67M | (m) | (m) | $7.61M | (m) | (m) |
| 2019-12-31 | $-22.24M | (m) | (m) | $6.79M | (m) | (m) |
| 2019-09-30 | $-18.76M | (m) | (m) | $5.68M | (m) | (m) |
| 2019-06-30 | $-16.53M | (m) | (m) | $5.58M | (m) | (m) |
| 2019-03-31 | $-15.29M | (m) | (m) | $6.40M | (m) | (m) |
| 2018-12-31 | $-15.20M | (m) | (m) | $6.51M | (m) | (m) |
| 2018-09-30 | $-15.05M | (m) | (m) | $6.82M | (m) | (m) |
| 2018-06-30 | $-18.86M | (m) | (m) | $7.13M | (m) | (m) |
| 2018-03-31 | $-18.22M | (m) | (m) | $6.80M | (m) | (m) |
| 2017-12-31 | $-18.85M | (m) | (m) | $7.17M | (m) | (m) |
| 2017-09-30 | $-18.05M | (m) | (m) | $7.10M | (m) | (m) |
| 2017-06-30 | $-13.80M | (m) | (m) | $6.62M | (m) | (m) |
| 2017-03-31 | $-12.74M | (m) | (m) | $5.82M | (m) | (m) |
| 2016-12-31 | $-11.14M | (m) | (m) | $5.68M | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $0.00 | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $-4.97M | (m) | (m) | $3.96M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |